No insider purchase over the last 90 days. The latest, by RAMESHBHAI MEGHJIBHAI PATEL, was filed 05 Jun 2023.
Epigral Limited, classified in the Chemicals sector, is a listed company. Its insiders report their share dealings to SEBI (PIT + SAST). Nothing new has been filed by managers of Epigral Limited in twelve months, the latest record being from 5 June 2023.
Our records for Epigral Limited go back to 2021, with 45 purchases and no sales on the open market in total.
Elsewhere in the same sector, our signals recently picked up insider purchases at Yara International ASA and Culp Inc. Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended March 2026 · cache
25 of 45 declarations
Epigral Limited is a company specializing in the chemistry and materials sector. It is listed on the XBOM market.